Please Wait...

State-of-the-Art Technology

Post-marketing research is evolving rapidly and becoming increasingly complex. Unfortunately, pre-marketing Randomized Controlled Trial (RCT) technology is often applied in the post-marketing arena. This is a mistake, as it can decrease overall study efficiencies and increase study costs. Bioclinica's Post-Approval Research division utilizes post-approval-specific technology to maximize study efficiencies and costs, and optimize study outcomes.

Increase Efficiencies to Decrease Costs

Post-approval research varies from large, simple post-approval studies to large, complex safety surveillance studies. Bioclinica's post-approval technology is able to accommodate all types of study designs. Armed with this flexibility and scalability, you can alleviate unnecessary steps associated with pre-market RCT technology and databases, decreasing overall study costs by 10-15%.

Leverage Real-Time Data for Deeper Insights

Our integrated technology infrastructure is specifically designed to support post-approval research. Through this flexible, scalable, and customizable system, you can:

  • Access unique datasets and analytics, including real-time study metrics, to achieve greater clarity into your study
  • Obtain project metrics and quality/performance indicators
  • Integrate datasets from multiple datasets, including eCRF, Patient Reported Outcomes (PRO), safety data, third-party vendor data, and more for deeper insights
  • View discrete datasets and access analytics across datasets in real-time to survey and monitor progress on a routine basis
  • Benefit from full transparency for all stakeholders around the globe
  • Implement the necessary strategies to meet protocol and regulatory requirements and protect your investments
  • Provide access to real-time metrics and reports to sponsors, physicians, patients, CROs, and vendors to increase accountability and engagement in the study


Conducting post-approval research requires a unique mindset and specialized infrastructure. Do you have what it takes?


Patient Centric Post-Approval Research: It's Time to Rethink How Post-Approval Studies Are Done


Maximize the ROI of Your Post-Approval Research

Download White Paper

Post-Approval Research

Download Brochure

Patient Outreach Center

Download Info Sheet

Program Coordinating Center

Download Info Sheet

Post-Marketing Research

Download Info Sheet


Leader in Clinical Trial
Management Solutions

Bioclinica is divided into three business segments so that we can provide expert service and multifaceted technologies. Our Medical Imaging and Biomarkers segment includes an Imaging Core Lab, a Cardiovascular Safety division, and a Biomarker Laboratory. Our eHealth segment comprises an eClinical Solutions Division along with Safety and Regulatory Solutions. Under the Global Clinical Research segment, we offer a network of research sites, patient recruitment, and a Post-Approval Research division.

Smiles all around on Pizza Day today for @bioclinica eHealth in Audubon compliments of our CTO Andrew Masters. This…
bioclinica (17 hours ago)
Missed Tuesday's webinar on agile #IRT? No worries! Catch it here > #Pharma #CRO #eClinical
bioclinica (19 hours ago)
RT @ACROhealth: Where do you stand on regulating #mHealth & #Wearables in #clinicalresearch? w/ @bioclinica, @ICONplc, @INC_Research https:…
bioclinica (2 days ago)
RT @ACROhealth: ICYMI: @CCTAwareness’ Infographic on #clinicaltrials awareness for #Alzheimer’s and Parkinson’s treatments.…
bioclinica (2 days ago)
RT @bioclinica: Culture of knowledge, passion, innovation. See what it means to work w industry's best. Explore @bioclinica Careers https:/…
bioclinica (2 days ago)
Thnx everyone who joined our agile #IRT webinar. And thnx to our presenters Amanda NIte, Ken Clark.
bioclinica (2 days ago)

Latest Blogs: